China
China pushes expanded national maternity insurance systems in draft law
China pushes expanded national maternity insurance systems in draft law
Several regions have already expanded coverage to flexible workers.
17 hours ago
China’s healthcare index sinks 7.1% as investors pivot to tech AI
The sector’s stocks lag as AI inflows reshaped sector allocation patterns.
China healthcare firms offset policy pressure with global growth
Most major healthcare companies reported satisfactory 2025 financial results.
China Biopharma’s $56.7b deal boom signals pillar industry dominance
Out-licensing jumped 132% as sector becomes second-largest global hub.
Ping An Good Doctor projected to see 56% profit CAGR surge by 2027
Ali Health adjusted net profit forecast at 24% CAGR.
China captures 49% of global drug deals in 2025 amidst lower costs, faster timelines
This is an improvement from only 6% in 2020.
Strong pipeline, M&A activity could trigger rapid earnings for Greater China's healthcare firms: UOB
The industry is expected to become a key international player.
China commands 30% of global biopharma pipeline; drives Asia’s share to 43%
The country transitions from fast follower to global innovation frontrunner.
Greater China healthcare keeps 'overweight' rating as R&D, biotech drive expansion
Outlook still positive despite trade and regulatory risks.
TAC-302 therapy seizes bladder cure market lead in China
This comes as the population ages and chronic conditions rise.
Perennial Holdings launches Healthcare City in Chongqing, China
Its first phase involves a total investment of approximately $212.8m (RMB1.5b).
China medical device market grows at 8.1% CAGR through 2029
High costs remain a challenge despite expanding digital adoption.
Two Shanghai hospitals sign MoU to strengthen clinical collaboration
The partnership follows the recent opening of Parkway MediCentre Xintiandi.
Parkway MediCentre Xintiandi in Shanghai
It is connected to Parkway Shanghai Hospital and the Parkway 百汇医疗 clinic network.
China's licensing boom reshapes global pharma power
Record-breaking BD deals reflect Beijing's innovative assets are gaining massive international recognition.
Why China's pharma market is now a consumer game
Stakeholders must understand this moment, as it signifies a fundamental shift in the industry.
China’s pharma growth shifts from drugs to high-tech manufacturing
However, there is still a lot of pressure in pharmaceutical manufacturing.
Most Read
1. IHH Healthcare core profit up 3% in 2025 as revenue hits $6.6b 2. HKU develop RNA 'cut-and-patch' tool for treating neurodegenerative diseases 3. Immunotherapy boom drives demand for PET/CT imaging in Australia’s oncology sector 4. Oil shock hits Asia’s drugmakers as petrochemical crunch squeezes supply chains 5. Biomarkers market set for 11% CAGR on early detection pushResource Center
Read Here
Advertise
Sign Up
Event News
It will feature forums, demos, and business matching activities.
Commentary
How the healthcare ecosystem is responding to change the trajectory of myopia
Technology’s role in making Indian healthcare truly patient-centric